Trends in gastroesophageal reflux disease as measured by the national ambulatory medical care survey

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 1911-1917

  Friedenberg, Frank K ^a   Hanlon, Alexandra ^b   Vanar, Vishwas ^a   Nehemia, Dawit ^b   Mekapati, Jyothi ^a   Nelson, Deborah B ^b   Richter, Joel E ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Gastroesophageal reflux disease; National Ambulatory Medical Care Survey; Proton pump inhibitor

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; AMBULATORY CARE; ARTICLE; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROBABILITY;

ADULT; AGE DISTRIBUTION; AGED; AMBULATORY CARE; ANTI-ULCER AGENTS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OFFICE VISITS; PREVALENCE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 77954426893     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1004-0     Document Type: Article

References (29)

1. AG Klauser NE Schindlbeck SA Muller-Lissner 1990 Symptoms in gastro-oesophageal reflux disease Lancet 335 8683 205 208 10.1016/0140-6736(90) 90287-F 1967675 (Pubitemid 20054587)
2. I Hirano JE Richter 2007 Practice parameters committee of the American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing Am J Gastroenterol 102 3 668 685 10.1111/j.1572-0241.2006.00936.x 10.1111/j.1572-0241.2006.00936.x 17335450 (Pubitemid 46328165)
3. OT Nebel MF Fornes DO Castell 1976 Symptomatic gastroesophageal reflux: incidence and precipitating factors Am J Dig Dis 21 953 956 10.1007/BF01071906 10.1007/BF01071906 984016
4. G Kjellen L Tibbling 1981 Manometric oesophageal function, acid perfusion test and symptomatology in a 55-year-old general population Clin Physiol 1 4 405 415 10.1111/j.1475-097X.1981.tb00908.x 10.1111/j.1475-097X.1981.tb00908.x 6977428
5. WG Thompson KW Heaton 1982 Heartburn and globus in apparently healthy people Can Med Assoc J 126 1 46 48 7059872
6. M Ruth I Mansson N Sandberg 1991 The prevalence of symptoms suggestive of esophageal disorders Scand J Gastroenterol 26 1 73 81 10.3109/00365529108996486 10.3109/00365529108996486 2006401
7. GR Locke III NJ Talley SL Fett, et al. 1997 Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota Gastroenterology 112 5 1448 1456 10.1016/S0016-5085(97)70025-8 10.1016/S0016-5085(97)70025-8 9136821
8. E Kuster E Ros V Toledo-Pimentel, et al. 1994 Predictive factors of the long-term outcome in gastro-oesophageal reflux disease: six-year follow up of 107 patients Gut 35 1 8 14 10.1136/gut.35.1.8 10.1136/gut.35.1.8 8307456
9. NI McDougall BT Johnston F Kee, et al. 1996 Natural history of reflux oesophagitis: a 10-year follow up of its effect on patient symptomatology and quality of life Gut 38 4 481 486 10.1136/gut.38.4.481 10.1136/gut.38.4.481 8707073
10. L Agreus K Svardsudd NJ Talley, et al. 2001 Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study Am J Gastroenterol 96 10 2905 2914 11693325
11. PK Small MA Loudon B Waldron, et al. 1995 Importance of reflux symptoms in functional dyspepsia Gut 36 2 189 192 10.1136/gut.36.2.189 10.1136/gut.36.2.189 7883215
12. HB El-Serag NJ Petersen J Carter, et al. 2004 Gastroesophageal reflux among different racial groups in the United States Gastroenterology 126 7 1692 1699 10.1053/j.gastro.2004.03.077 10.1053/j.gastro.2004.03.077 15188164 (Pubitemid 38736334)
13. SJ Spechler SK Jain DA Tendler, et al. 2002 Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 10 1795 1800 10.1046/j.1365-2036.2002.01351.x 10.1046/j.1365-2036.2002.01351.x 12269973
14. CW Burt E Hing 2007 Making patient-level estimates from medical encounter records using a multiplicity estimator Stat Med 26 8 1762 1774 10.1002/sim.2797 10.1002/sim.2797 17221943 (Pubitemid 46455634)
15. DO Castell 1999 A practical approach to heartburn Hosp Pract (Minneap) 34 12 89 94 10.3810/hp.1999.11.172 97-98
16. JR Avasarala CA O'Donovan SE Roach, et al. 2007 Analysis of NAMCS data for multiple sclerosis, 1998-2004 BMC Med 5 6 10.1186/1741-7015-5-6 10.1186/1741-7015-5-6 17411425 (Pubitemid 46681523)
17. R Balkrishnan JC Sansbury RA Shenolikar, et al. 2005 Prescribing patterns for topical retinoids within NAMCS data J Drugs Dermatol 4 2 172 179 15776774
18. AK Gupta EA Cooper SR Feldman, et al. 2002 A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey Cutis 70 Suppl(2) 8 13 12353680
19. J Quinn D McDermott 2005 Syncope and NAMCS Acad Emerg Med 12 4 381 10.1111/j.1553-2712.2005.tb01964.x 10.1111/j.1553-2712.2005.tb01964.x 15805334 Author reply 381-2
20. SH Scholle J Chang J Harman, et al. 2004 Characteristics of patients seen and services provided in primary care visits in obstetrics/gynecology: data from NAMCS and NHAMCS Am J Obstet Gynecol 190 4 1119 1127 10.1016/j.ajog.2003. 09.059 10.1016/j.ajog.2003.09.059 15118652 (Pubitemid 38561535)
21. SH Scholle JC Chang J Harman, et al. 2002 Trends in women's health services by type of physician seen: data from the 1985 and 1997-98 NAMCS Womens Health Issues 12 4 165 177 10.1016/S1049-3867(02)00139-1 10.1016/S1049-3867(02) 00139-1 12093581 (Pubitemid 34687083)
22. J Dent HB El-Serag MA Wallander, et al. 2005 Epidemiology of gastro-oesophageal reflux disease: a systematic review Gut 54 5 710 717 10.1136/gut.2004.051821 10.1136/gut.2004.051821 15831922 (Pubitemid 40559260)
23. J Lagergren R Bergstrom O Nyren 1999 Association between body mass and adenocarcinoma of the esophagus and gastric cardia Ann Intern Med 130 11 883 890 10375336
24. ZR Edelstein DC Farrow MP Bronner, et al. 2007 Central adiposity and risk of Barrett's esophagus Gastroenterology 133 2 403 411 10.1053/j.gastro.2007.05. 026 10.1053/j.gastro.2007.05.026 17681161 (Pubitemid 47187351)
25. J Hughes J Lockhart A Joyce 2007 Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Clin Pharmacol 64 1 83 89 10.1111/j.1365-2125.2007.02851.x 10.1111/j.1365-2125. 2007.02851.x 17298478 (Pubitemid 46934417)
26. LR Jenkinson TL Norris A Watson 1988 Gastro-oesophageal reflux associated with nifedipine Aliment Pharmacol Ther 2 4 337 339 2979256
27. J Lagergren R Bergstrom HO Adami O Nyren 2000 Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma Ann Intern Med 133 165 175 10906830
28. GR Locke III NJ Talley SL Fett, et al. 1999 Risk factors associated with symptoms of gastroesophageal reflux Am J Med 106 642 649 10.1016/S0002-9343(99) 00121-7 10378622 (Pubitemid 29279301)
29. A Ruigomez MA Wallander S Johansson, et al. 2004 Natural history of gastroesophageal reflux disease diagnosed in UK general practice Aliment Pharmacol Ther 20 751 760 10.1111/j.1365-2036.2004.02169.x 15379835 (Pubitemid 39319230)